vs
艾默生(EMR)与Rocket Companies, Inc.(RKT)财务数据对比。点击上方公司名可切换其他公司
艾默生的季度营收约是Rocket Companies, Inc.的1.6倍($4.3B vs $2.7B),艾默生净利率更高(13.9% vs 2.5%,领先11.4%),Rocket Companies, Inc.同比增速更快(52.2% vs 4.1%),艾默生自由现金流更多($602.0M vs $-1.3B),过去两年Rocket Companies, Inc.的营收复合增速更高(39.5% vs -0.3%)
艾默生是总部位于美国密苏里州圣路易斯的世界500强跨国企业,业务涵盖工业自动化设备、暖通控制系统、精密测量仪器的研发制造,同时面向工业、商业、消费级市场提供工程服务及对应软件工程解决方案。
Rocket Companies, Inc.是美国金融科技及住房服务企业,由丹·吉尔伯特创立,总部位于密歇根州底特律市中心。公司依托旗舰子公司Rocket Mortgage跻身美国最大抵押贷款提供商行列,旗下还拥有Redfin、Forsalebyowner.com、Rocket Money等子品牌。
EMR vs RKT — 直观对比
营收规模更大
EMR
是对方的1.6倍
$2.7B
营收增速更快
RKT
高出48.1%
4.1%
净利率更高
EMR
高出11.4%
2.5%
自由现金流更多
EMR
多$1.9B
$-1.3B
两年增速更快
RKT
近两年复合增速
-0.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $4.3B | $2.7B |
| 净利润 | $605.0M | $68.0M |
| 毛利率 | 53.2% | — |
| 营业利润率 | 17.8% | 6.3% |
| 净利率 | 13.9% | 2.5% |
| 营收同比 | 4.1% | 52.2% |
| 净利润同比 | 3.4% | 100.8% |
| 每股收益(稀释后) | $1.07 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
EMR
RKT
| Q4 25 | $4.3B | $2.7B | ||
| Q3 25 | $4.9B | $1.6B | ||
| Q2 25 | $4.6B | $1.4B | ||
| Q1 25 | $4.4B | $1.0B | ||
| Q4 24 | $4.2B | $1.8B | ||
| Q3 24 | $4.6B | $646.9M | ||
| Q2 24 | $4.4B | $1.3B | ||
| Q1 24 | $4.4B | $1.4B |
净利润
EMR
RKT
| Q4 25 | $605.0M | $68.0M | ||
| Q3 25 | $637.0M | $-123.9M | ||
| Q2 25 | $586.0M | $-1.8M | ||
| Q1 25 | $485.0M | $-10.4M | ||
| Q4 24 | $585.0M | $33.9M | ||
| Q3 24 | $996.0M | $-22.0M | ||
| Q2 24 | $329.0M | $1.3M | ||
| Q1 24 | $501.0M | $16.2M |
毛利率
EMR
RKT
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.9% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.5% | 58.9% | ||
| Q3 24 | 51.3% | -8.4% | ||
| Q2 24 | 52.8% | 47.4% | ||
| Q1 24 | 52.2% | 51.2% |
营业利润率
EMR
RKT
| Q4 25 | 17.8% | 6.3% | ||
| Q3 25 | 16.4% | -11.5% | ||
| Q2 25 | 16.1% | 1.8% | ||
| Q1 25 | 14.2% | -21.5% | ||
| Q4 24 | 18.6% | 38.1% | ||
| Q3 24 | 14.7% | -76.9% | ||
| Q2 24 | 10.4% | 14.8% | ||
| Q1 24 | 16.2% | 21.6% |
净利率
EMR
RKT
| Q4 25 | 13.9% | 2.5% | ||
| Q3 25 | 13.1% | -7.7% | ||
| Q2 25 | 12.9% | -0.1% | ||
| Q1 25 | 10.9% | -1.0% | ||
| Q4 24 | 14.0% | 1.9% | ||
| Q3 24 | 21.6% | -3.4% | ||
| Q2 24 | 7.5% | 0.1% | ||
| Q1 24 | 11.4% | 1.2% |
每股收益(稀释后)
EMR
RKT
| Q4 25 | $1.07 | $0.10 | ||
| Q3 25 | $1.12 | $-0.06 | ||
| Q2 25 | $1.04 | $-0.01 | ||
| Q1 25 | $0.86 | $-0.08 | ||
| Q4 24 | $1.02 | $0.28 | ||
| Q3 24 | $1.74 | $-0.19 | ||
| Q2 24 | $0.57 | $0.01 | ||
| Q1 24 | $0.87 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $2.7B |
| 总债务越低越好 | $7.6B | — |
| 股东权益账面价值 | $20.3B | $22.9B |
| 总资产 | $41.9B | $60.7B |
| 负债/权益比越低杠杆越低 | 0.37× | — |
8季度趋势,按日历期对齐
现金及短期投资
EMR
RKT
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | $5.8B | ||
| Q2 25 | — | $5.1B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $861.4M |
总债务
EMR
RKT
| Q4 25 | $7.6B | — | ||
| Q3 25 | $8.9B | — | ||
| Q2 25 | $8.3B | — | ||
| Q1 25 | $8.2B | — | ||
| Q4 24 | $6.6B | — | ||
| Q3 24 | $7.7B | — | ||
| Q2 24 | $7.1B | — | ||
| Q1 24 | $7.6B | — |
股东权益
EMR
RKT
| Q4 25 | $20.3B | $22.9B | ||
| Q3 25 | $20.3B | $8.9B | ||
| Q2 25 | $19.9B | $7.4B | ||
| Q1 25 | $19.2B | $8.6B | ||
| Q4 24 | $20.5B | $9.0B | ||
| Q3 24 | $21.6B | $8.4B | ||
| Q2 24 | $20.8B | $8.8B | ||
| Q1 24 | $20.9B | $8.6B |
总资产
EMR
RKT
| Q4 25 | $41.9B | $60.7B | ||
| Q3 25 | $42.0B | $33.6B | ||
| Q2 25 | $42.5B | $30.4B | ||
| Q1 25 | $42.0B | $25.3B | ||
| Q4 24 | $42.6B | $24.5B | ||
| Q3 24 | $44.2B | $25.1B | ||
| Q2 24 | $45.6B | $23.6B | ||
| Q1 24 | $46.4B | $22.2B |
负债/权益比
EMR
RKT
| Q4 25 | 0.37× | — | ||
| Q3 25 | 0.44× | — | ||
| Q2 25 | 0.42× | — | ||
| Q1 25 | 0.42× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.36× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $699.0M | $-1.2B |
| 自由现金流经营现金流 - 资本支出 | $602.0M | $-1.3B |
| 自由现金流率自由现金流/营收 | 13.9% | -47.2% |
| 资本支出强度资本支出/营收 | 2.2% | 1.5% |
| 现金转化率经营现金流/净利润 | 1.16× | -18.08× |
| 过去12个月自由现金流最近4个季度 | $4.4B | $-4.0B |
8季度趋势,按日历期对齐
经营现金流
EMR
RKT
| Q4 25 | $699.0M | $-1.2B | ||
| Q3 25 | $3.1B | $-50.3M | ||
| Q2 25 | $1.1B | $-1.9B | ||
| Q1 25 | $241.0M | $-797.0M | ||
| Q4 24 | $777.0M | $1.8B | ||
| Q3 24 | $3.3B | $-1.3B | ||
| Q2 24 | $1.1B | $-122.3M | ||
| Q1 24 | $743.0M | $-3.0B |
自由现金流
EMR
RKT
| Q4 25 | $602.0M | $-1.3B | ||
| Q3 25 | $2.7B | $-71.8M | ||
| Q2 25 | $977.0M | $-1.9B | ||
| Q1 25 | $154.0M | $-811.0M | ||
| Q4 24 | $694.0M | $1.8B | ||
| Q3 24 | $2.9B | $-1.4B | ||
| Q2 24 | $998.0M | $-138.3M | ||
| Q1 24 | $661.0M | $-3.0B |
自由现金流率
EMR
RKT
| Q4 25 | 13.9% | -47.2% | ||
| Q3 25 | 54.9% | -4.5% | ||
| Q2 25 | 21.5% | -137.2% | ||
| Q1 25 | 3.5% | -78.2% | ||
| Q4 24 | 16.6% | 103.1% | ||
| Q3 24 | 63.1% | -209.6% | ||
| Q2 24 | 22.8% | -10.6% | ||
| Q1 24 | 15.1% | -218.7% |
资本支出强度
EMR
RKT
| Q4 25 | 2.2% | 1.5% | ||
| Q3 25 | 8.9% | 1.3% | ||
| Q2 25 | 2.0% | 1.1% | ||
| Q1 25 | 2.0% | 1.4% | ||
| Q4 24 | 2.0% | 1.1% | ||
| Q3 24 | 9.1% | 2.9% | ||
| Q2 24 | 2.1% | 1.2% | ||
| Q1 24 | 1.9% | 1.0% |
现金转化率
EMR
RKT
| Q4 25 | 1.16× | -18.08× | ||
| Q3 25 | 4.86× | — | ||
| Q2 25 | 1.83× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 1.33× | 54.42× | ||
| Q3 24 | 3.35× | — | ||
| Q2 24 | 3.31× | -94.46× | ||
| Q1 24 | 1.48× | -185.80× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EMR
| Other | $1.8B | 41% |
| Software And Systems | $1.0B | 24% |
| Intelligent Devices | $996.0M | 23% |
| Safety And Productivity | $503.0M | 12% |
RKT
| Other | $1.4B | 51% |
| Direct To Customer Segment | $945.8M | 35% |
| Partner Network Segment | $216.7M | 8% |
| Subscription Revenue | $91.3M | 3% |
| Closing Fees | $47.1M | 2% |
| Appraisal Revenue | $10.7M | 0% |